NewAmsterdam Pharma Co N.V. (NAMS): Weighted Average Diluted Shares
118.42M
Year ended 2025-12-31
+84.1%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 118.42M | +25.5% | 2026-02-18, From 2025-01-01 |
| 2024-12-31 | 94.36M | +14.8% | 2026-02-18, From 2024-01-01 |
| 2023-12-31 | 82.16M | +333.2% | 2026-02-18, From 2023-01-01 |
| 2022-12-31 | 18.97M | +72.8% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | 10.98M | n/a | 2024-02-28, From 2021-01-01 |